Cardiovascular disease (CVD) is the leading cause of death among individuals with type II diabetes mellitus.\[[@ref1]--[@ref4]\] Diabetics are twice more likely to die of CVD than non-diabetics.\[[@ref5]\] There has been increasing evidence indicating an association between CVD and diabetic retinopathy (DR).\[[@ref1]--[@ref9]\] A recent evidence from the Atherosclerosis Risk In Communities (ARIC) study suggests that the risk of developing CVD increased twofold, with the presence of DR.\[[@ref10]\] Thus, there seems to be an overlap of risk factors between CVD and DR.

The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and the Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) guidelines recommend using the Framingham risk scores to assess the absolute risk of type II diabetics developing CVD.\[[@ref9]\] Framingham scoring is used for clinical management of asymptomatic patients for primary prevention.\[[@ref9]--[@ref11]\] However, whether the same scoring can predict the occurrence of DR or sight-threatening DR has not been explored.

Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS) was a population-based, cross-sectional study carried out to estimate the prevalence and risk factors of DR in urban India.\[[@ref12]\]

The aim of the present study was to know the 10-year CVD risk among subjects with type II diabetes enrolled in SN-DREAMS, to elucidate the correlation between DR and Framingham risk scores, and to assess the risk factors for DR in subjects with low risk of developing CVD against those with high risk.

Materials and Methods {#sec1-1}
=====================

The study design and research methodology of SN-DREAMS 1 is described in detail elsewhere.\[[@ref12]\] The study population was selected by multistage systematic random sampling, based on the socioeconomic status, which made the sample a true representation of Chennai, Tamil Nadu, India. Out of the 5999 individuals, aged ≥40 years, who were enumerated from the general population, 1816 subjects had diabetes (known 1349 and provisional 469); 1563 (86.1%) came for further evaluation at the base hospital out of whom only 1414 subjects were finally confirmed as diabetics (11 excluded due to non-gradable photographs); and 138 subjects with no diabetes were excluded.

The 10-year risk of developing CVD was evaluated for 1248 subjects (166 excluded due to previous history of CVD). Identified diabetics (based on the WHO criteria) underwent a detailed examination at the base hospital.\[[@ref12]\] The fundi of all patients were photographed using the 45°, four-field stereoscopic digital photography. DR was diagnosed based on the modified Klein classification of the Early Treatment Diabetic Retinopathy Study scale.\[[@ref12]\] Severe non-proliferative DR, proliferative DR and clinically significant macular edema were categorized as sight-threatening DR. This grading was done by two independent observers in a masked fashion; the grading agreement was high (k = 0.83).\[[@ref12]\]

The study was approved by the organization\'s Institutional Review Board, and written consent was obtained from the subjects as per the Helsinki Declaration.\[[@ref12]\]

Detailed history of the patients, including demographic data, socioeconomic status, physical activity, dietary habits, and anthropometric measurements, was collected. A detailed medical and ocular history and a comprehensive eye examination, including stereo fundus photographs, were taken at the base hospital. Biochemical investigations (blood sugar, total serum cholesterol, high-density lipoproteins, serum triglycerides, hemoglobin, glycosylated hemoglobin HbA1c) were conducted at the base hospital in fasting state.

The 10-year risk for developing CVD was estimated using the Framingham risk scores.\[[@ref9]--[@ref11]\] The different variables included in the scoring were age, serum total cholesterol, serum high density lipoprotein (HDL) cholesterol, systolic blood pressure, treatment for hypertension, and smoking status. Details about this tool are mentioned elsewhere.\[[@ref9]\] The score was classified as high risk (\>10%), and low risk (\<10%).\[[@ref9]\]

The proportion of a 10-year risk of developing CVD was calculated with the following formula:
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where S(t) = probability of survival at time "t", β = Cox parameter coefficient (total serum cholesterol, smoking status, HDL, systolic blood pressure), and exp = exponential.

Statistical analysis {#sec2-1}
--------------------

SPSS (version 14.0) was used for statistical analysis. The prevalence was expressed as percentage with a 95% confidence interval (CI). The data were normally distributed. A test of significance such as chi-square test was performed for comparison of prevalence in of low and high risk for developing CVD. Univariate and stepwise multivariate logistic regression analyses were performed to elucidate the risk factors influencing the presence and severity of DR. The dependent variables were DR and no DR; duration of diabetes, HbA1c, presence of macro and microalbuminuria, use of insulin, etc. were the independent variables. Adjusted Odds ratios and their 95% CI values were estimated. A "*P*" value of less than 0.05 was considered statistically significant.

Results {#sec1-2}
=======

[Table 1](#T1){ref-type="table"} shows the prevalence of the 10-year risk of developing CVD among type II diabetes mellitus subjects to be 33.5% (95% CI 30.9--36.1). The risk of CVD was more in men than women (56.8% vs. 7%). The number of subjects with an increased risk of developing CVD increases up to 70 years (7.4% in 40--49 years to 38.8% in 60--69 years; *P* \< 0.0001). The same trend was seen in both genders.

###### 

Age and gender prevalence of subjects with low and increased 10-year risk of developing cardiovascular diseases
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[Fig. 1](#F1){ref-type="fig"} shows the prevalence of DR and sight-threatening retinopathy among subjects with high and low risk of developing CVD. The prevalence of both DR and sight-threatening retinopathy was more in the high-risk group (21% and 4.5%, respectively) when compared to the low-risk group (16.6% and 2.4%, respectively; *P* = 0.044 and 0.041, respectively.

![Prevalence of diabetic retinopathy and sight-threatening diabetic retinopathy in subgroups (DR: Diabetic retinopathy, STDR: Sight threatening diabetic retinopathy, CVD: Cardiovascular diseases)](IJO-60-45-g003){#F1}

Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"} represent the results of stepwise forward and backward logistic regression analyses in two groups: subjects who had low risk of developing CVD and those who had a high risk of developing CVD, respectively. In the low-risk group, the risk factors independently associated with any DR, in order of importance, included increasing duration of diabetes (Odds for per year increase 1.14), glycosylated hemoglobin (Odds for per unit increase 1.24), presence of macroalbuminuria (Odds 10.17), body mass index (BMI; Odds for per unit increase 0.93), presence of microalbuminuria (Odds 1.87) and use of insulin (Odds 2.06).

###### 

Stepwise multiple regression model for risk factors for the presence of any diabetic retinopathy in the group with 10-year low risk of cardiovascular diseases
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###### 

Stepwise multiple logistic regression analysis for risk factors for presence of any diabetic retinopathy in the group with 10-year increased risk of cardiovascular diseases
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In the high-risk group, the risk factors independently associated with any DR, in order of importance, included increasing duration of diabetes (Odds for per year increase 1.08), glycosylated hemoglobin (Odds for per unit increase 1.22), presence of anemia (Odds 2.65), use of insulin (Odds 4.38), serum HDL cholesterol (Odds for per unit increase 1.05), presence of macroalbuminuria (Odds 6.12) and presence of microalbuminuria (Odds 2.28).

Discussion {#sec1-3}
==========

We reported the 10-year risk of developing CVD among type II diabetic subjects in a population-based study. On the basis of the Framingham risk scores, nearly one-third of the subjects recruited for the study will have CVD at the end of 10 years. For over a decade, the Framingham risk score has been used to predict the 10-year risk of developing CVD in people with no history of CVD.\[[@ref13]--[@ref15]\]

We found that the risk of developing CVD was more in males than in females. In general, males have a higher risk of CVD than females, but the gender difference was smaller in subjects with type II diabetes.\[[@ref13]--[@ref18]\]

The United kingdom Prospective Diabetes Study (UKPDS) used the Framingham scores and found that among subjects with type II diabetes, the 10-year risk of developing CVD was 28%; however, on longitudinal follow-up, there was an underestimation of the risk by 32%.\[[@ref16]--[@ref20]\] Similarly, another study in Spain found that the scores overestimated the risk in both genders.\[[@ref19]\] There is no longitudinal study from India which can suggest whether the scores underestimate or overestimate the CVD risk among subjects with type II diabetes.

We found that the severity of DR and sight-threatening DR was more in subjects in the high-risk group than in the low-risk group. Similar to our study, the ARIC study also found that the chances of developing CVD, over 7.8 years of follow-up, increased twofold with the presence of DR.\[[@ref10][@ref20]\] Gimeno-Orna *et al*. also found that the presence of baseline retinopathy was associated with CVD irrespective of other cardiovascular risk factors.\[[@ref21]\]

We also described the risk factors for DR in the low-risk and high-risk groups. The unique factors in the high-risk group included presence of anemia and higher serum HDL cholesterol. Other factors were common in both the groups. Anemia and serum HDL cholesterol were associated with both CVD and DR.

The strengths of this study are its standardized photographic documentation and its population-based sample. The findings of the study can be extrapolated to the urban Indian population. The inherent cross-sectional design and the lack of follow-up are the limitations of this study.

In conclusion, the Framingham risk score, a global risk assessment tool for predicting the 10-year risk of developing CVD, can also predict the occurrence of DR. Understanding the risk factors in subjects with a high risk of developing CVD can help implement preventive strategies like frequent follow-up and early and adequate laser treatment to reduce the burden of blindness due to DR.

Further follow-up studies are warranted to know the incidence of CVD and DR in population-based samples.
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